HomeCCCC • NASDAQ
add
C4 Therapeutics Inc
Previous close
$2.72
Day range
$2.68 - $2.88
Year range
$1.09 - $3.82
Market cap
266.39M USD
Avg Volume
2.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 11.02M | 112.79% |
Operating expense | 104.44M | -3.71% |
Net income | -20.49M | 40.75% |
Net profit margin | -185.97 | 72.15% |
Earnings per share | -0.18 | 63.27% |
EBITDA | -22.72M | 38.98% |
Effective tax rate | -0.59% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 248.54M | 1.48% |
Total assets | 359.08M | 2.71% |
Total liabilities | 102.49M | -23.30% |
Total equity | 256.59M | — |
Shares outstanding | 97.58M | — |
Price to book | 1.03 | — |
Return on assets | -18.53% | — |
Return on capital | -21.73% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -20.49M | 40.75% |
Cash from operations | -22.14M | -23.49% |
Cash from investing | -80.73M | -690.59% |
Cash from financing | 118.67M | 105,857.14% |
Net change in cash | 15.79M | 480.58% |
Free cash flow | -7.70M | 8.17% |
About
Founded
2015
Headquarters
Website
Employees
104
